Clinical Trial Update: A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase III trial evaluating saxagliptin co-administered with dapagliflozin as add-on therapy to metformin in type 2 diabetes with inadequate glycemic control; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (saxagliptin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus, Inadequate Glycaemic Control | Phase 3 | Status: COMPLETED | Results posted: 2018-10-10